Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial

Andreas Munk Petersen; Hengameh Chloé Lauridsen; Sofie Ingdam Halkjær; Esben Munk Mortensen; Inge Nordgaard-Lassen; Karen Angeliki Krogfelt

doi:10.1016/j.crohns.2014.06.001

Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial

Andreas Munk Petersen^*, Hengameh Chloé Lauridsen, Sofie Ingdam Halkjær, Esben Munk Mortensen, Inge Nordgaard-Lassen, Karen Angeliki Krogfelt

^*Corresponding author

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Journal of Crohn's and Colitis
Vol/bind	8
Udgave nummer	11
Sider (fra-til)	1498-1505
Antal sider	8
ISSN	1873-9946
DOI	https://doi.org/10.1016/j.crohns.2014.06.001
Status	Udgivet - 2014
Udgivet eksternt	Ja

Link til dokument

10.1016/j.crohns.2014.06.001

Citer dette

Petersen, A. M., Lauridsen, H. C., Halkjær, S. I., Mortensen, E. M., Nordgaard-Lassen, I., & Krogfelt, K. A. (2014). Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial. Journal of Crohn's and Colitis, 8(11), 1498-1505. https://doi.org/10.1016/j.crohns.2014.06.001

Petersen, Andreas Munk ; Lauridsen, Hengameh Chloé ; Halkjær, Sofie Ingdam ; Mortensen, Esben Munk ; Nordgaard-Lassen, Inge ; Krogfelt, Karen Angeliki. / Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis : a double-blind randomized placebo controlled clinical trial. I: Journal of Crohn's and Colitis. 2014 ; Bind 8, Nr. 11. s. 1498-1505.

@article{94e9c89adaba4adfabc480f56dffc358,

title = "Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial",

author = "Petersen, {Andreas Munk} and Lauridsen, {Hengameh Chlo{\'e}} and Halkj{\ae}r, {Sofie Ingdam} and Mortensen, {Esben Munk} and Inge Nordgaard-Lassen and Krogfelt, {Karen Angeliki}",

year = "2014",

doi = "10.1016/j.crohns.2014.06.001",

language = "English",

volume = "8",

pages = "1498--1505",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

number = "11",

}

Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis : a double-blind randomized placebo controlled clinical trial. / Petersen, Andreas Munk; Lauridsen, Hengameh Chloé; Halkjær, Sofie Ingdam; Mortensen, Esben Munk; Nordgaard-Lassen, Inge; Krogfelt, Karen Angeliki.

I: Journal of Crohn's and Colitis, Bind 8, Nr. 11, 2014, s. 1498-1505.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

TY - JOUR

T1 - Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis

T2 - a double-blind randomized placebo controlled clinical trial

AU - Petersen, Andreas Munk

AU - Lauridsen, Hengameh Chloé

AU - Halkjær, Sofie Ingdam

AU - Mortensen, Esben Munk

AU - Nordgaard-Lassen, Inge

AU - Krogfelt, Karen Angeliki

PY - 2014

Y1 - 2014

U2 - 10.1016/j.crohns.2014.06.001

DO - 10.1016/j.crohns.2014.06.001

M3 - Journal article

VL - 8

SP - 1498

EP - 1505

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

IS - 11

ER -